A little bit of profit taking on the news but China generally copies the US and need the drug too so I would expect Nina and the team to move forward with the US validation and close the next big one out along with a lot more smaller ones in the process. Targeting $1.20+ in short term here personally. DYOR
Ann: Dimerix receives initial upfront payment from Amicus, page-25
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.055(10.8%) |
Mkt cap ! $333.3M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 56.5¢ | 52.0¢ | $1.136M | 2.073M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42908 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 31479 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |